The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
PepsiCo Inc
SIX:PEP
|
US |
|
Y
|
Yes 24 Co Ltd
KOSDAQ:053280
|
KR |
|
B
|
BYD Co Ltd
XMUN:BY6A
|
CN |
|
S
|
Siemens Energy AG
XMUN:ENR
|
DE |
|
Industrivarden AB
F:IDV1
|
SE |
|
Korro Bio Inc
NASDAQ:KRRO
|
US |
|
Nippon Care Supply Co Ltd
TSE:2393
|
JP |
|
Funai Soken Holdings Inc
TSE:9757
|
JP |
|
M
|
MGM Resorts International
DUS:MGG
|
US |
|
Gateway Mining Ltd
ASX:GML
|
AU |
|
Bouygues SA
PAR:EN
|
FR |
|
C
|
CT Automotive Group PLC
LSE:CTA
|
UK |
|
Silex Systems Ltd
ASX:SLX
|
AU |
|
E
|
enGene Therapeutics Inc
NASDAQ:ENGN
|
CA |
|
T
|
Toray Industries Inc
F:TOR1
|
JP |
|
M
|
Mudanjiang Hengfeng Paper Co Ltd
SSE:600356
|
CN |
|
B
|
Bechtle AG
XHAM:BC8
|
DE |
|
B
|
biote Corp
NASDAQ:BTMD
|
US |
|
V
|
Vistance Networks Inc
XMUN:CM9
|
US |
|
H
|
H&R GmbH & Co KgaA
XHAM:2HRA
|
DE |
|
C
|
Celsius Resources Ltd
F:FX8
|
AU |
|
P
|
Pinnacle West Capital Corp
LSE:0KIT
|
US |
PepsiCo Inc (PEP)’s 12-month stock price forecast through March 2025 has a consensus target of CHf133.9039, implying 6% downside. The forecast is based on price targets from 26 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
PEP is 133.9039 CHF with a low forecast of 107.4595 CHF and a high forecast of 162.1674 CHF.
Over the last 13 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 8 years is 4%.
Over the last 13 years, the compound annual growth rate for Gross Profit has been 3%. The projected CAGR for the next 3 years is 4%.
Over the last 13 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 8 years is 4%.
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 2%. The projected CAGR for the next 3 years is 17%.
Over the last 13 years, the compound annual growth rate for Net Income has been 2%. The projected CAGR for the next 8 years is 9%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more